This is just the another absurd thing. BLA (Bangkok Life Assurance) is a decent company with consistent operating profits (2-3 Baht per share/year). It is now trading at 12 Baht! The price is at 46% of the book value! ( It was trading at the high of about 300% of the book value back in 2015) And, it is trading at the P/E of 4.67! It is a big company. So the...
In the HSGX longs community (i.e. Stocktwits) it is expected that there will be another update by the company CEO Adam Grizley by the end of year. As there haven't been any updates on the FDA discussions concerning BLA submission since 11-29-2018. The product NeoCart failed phase 3 because it didn't meet Histogenics criteria, not the FDA's. While the FDA continue...